News | Prostate Cancer | June 14, 2018

Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program

Hitachi to supply Arietta ultrasound and BiopSee systems to improve prostate cancer diagnosis in new RAPID program

Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program

June 14, 2018 — Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID program to improve prostate cancer diagnosis across South West London. In addition to the six high-resolution Arietta ultrasound systems, the contract also includes six BiopSee image-guided fusion biopsy systems from MedCom (for which Hitachi is a European distributor) to be installed at three major hospitals. Using the two systems together will allow providers to combine multiparametric magnetic resonance imaging (mp-MRI) data with real-time ultrasound, reducing unnecessary biopsies and providing accurate targeting while reducing the number of samples needed.

The pilots for the RAPID (Rapid Assessment Prostate Imaging and Diagnosis) program have been developed through funding from RM Partners, the Cancer Alliance for west London hosted by The Royal Marsden. Three trusts are piloting RAPID – Epsom and St Helier University Hospitals NHS Trust, Imperial College Healthcare NHS Trust, and St George’s University Hospitals NHS Foundation Trust.

The RAPID approach involves the patient having an mp-MRI scan in the morning and reported immediately. If it shows areas of abnormality, the patient will then undergo a transperineal ultrasound fusion biopsy, all within the same day.

The transperineal approach, in which samples are taken through the perineum rather than the rectum, confers a comparatively low risk of sepsis, and can obviate the need for broad spectrum antibiotics and the possible development of antibiotic resistance.

Hashim Ahmed, professor and chair of urology, Imperial College London, said, “After trialling various systems on the market we felt that the Hitachi Arietta and MedCom BiopSee combination offered us the best in high-resolution imaging together with precise, accurate needle placement and an easy streamlined fusion software interface. This will help deliver a faster diagnosis and treatment for prostate cancer and reduce waiting times. The safer transperineal biopsy route will also reduce infection and life-threatening sepsis rates.”

The BiopSee system fuses the mp-MRI images with the Hitachi ultrasound images in real-time, allowing highly accurate placement of the biopsy needle in the prostate to target the tumour with exceptional precision. Three-dimensional ultrasound image acquisition, rigid/elastic fusion capabilities together with precise stepper tracking and reporting software deliver an exceptional diagnostic platform supporting the RAPID programme in London.

BiopSee records and stores the location of each tissue sample. This provides comprehensive documentation and reporting of biopsy core locations for accurate management of patients requiring further treatment and therapy planning in cryotherapy, brachytherapy, high intensity focused ultrasound (HIFU), radiofrequency (RF) or other treatment programmes.

Prostate cancer diagnosis has become a national health priority in the U.K., with Prime Minister Theresa May announcing in April the government’s £75m prostate cancer drive to be administered via the National Institute for Health Research clinical research network. This initiative will see 40,000 men recruited for research into the disease, which kills more than 11,000 a year and causes great anxiety and sometimes suffering for the 47,000 men who get a diagnosis.

For more information: www.hitachi-medical-systems.eu

Related Content

Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine

Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine. Photo credit: Tech Parks Arizona

News | Ultrasound Imaging | February 27, 2020
February 27, 2020 — Emagine Solutions Technology, an award-winnin
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer

From left: Peter Ström, Martin Eklund, Kimmo Kartasalo, Henrik Olsson och Lars Egevad, researchers at Karolinska Institutet in Sweden. Photo courtesy of Stefan Zimmerman

News | Prostate Cancer | January 20, 2020
January 20, 2020 — Researchers at Karolinska Institutet in Sweden and...
Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population. Chart courtesy of the American Cancer Society

News | Radiation Oncology | January 13, 2020
January 13, 2020 — The cancer death rate declined